Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
everolimus (zortress) (1 trial)
pep-cmv (1 trial)
trametinib (mekinist) (1 trial)
Brain Neoplasms (Phase 1)
Glioma (Phase 1)
Medulloblastoma (Phase 1)
Trials (2 total)
Trial APIs (3 total)